O. Sanmartín

2.3k total citations
105 papers, 1.4k citations indexed

About

O. Sanmartín is a scholar working on Dermatology, Oncology and Epidemiology. According to data from OpenAlex, O. Sanmartín has authored 105 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Dermatology, 55 papers in Oncology and 48 papers in Epidemiology. Recurrent topics in O. Sanmartín's work include Nonmelanoma Skin Cancer Studies (33 papers), Cutaneous Melanoma Detection and Management (20 papers) and Cutaneous lymphoproliferative disorders research (20 papers). O. Sanmartín is often cited by papers focused on Nonmelanoma Skin Cancer Studies (33 papers), Cutaneous Melanoma Detection and Management (20 papers) and Cutaneous lymphoproliferative disorders research (20 papers). O. Sanmartín collaborates with scholars based in Spain, United States and Italy. O. Sanmartín's co-authors include B. Llombart, C. Guillén, Celia Requena, C. Serra‐Guillén, Eduardo Nagore, Rafael Botella‐Estrada, Antonio Martorell, L. Hueso, V. Través and Carlos Serra and has published in prestigious journals such as Journal of the American Academy of Dermatology, British Journal of Dermatology and Histopathology.

In The Last Decade

O. Sanmartín

103 papers receiving 1.3k citations

Peers

O. Sanmartín
James W. Patterson United States
B. Llombart Spain
Wolfgang Weyers Germany
H. Adamski France
Gisela Metzler Germany
John S. Metcalf United States
Uma Sundram United States
Stephen N. Snow United States
Jere B. Stern United States
A Margulis France
James W. Patterson United States
O. Sanmartín
Citations per year, relative to O. Sanmartín O. Sanmartín (= 1×) peers James W. Patterson

Countries citing papers authored by O. Sanmartín

Since Specialization
Citations

This map shows the geographic impact of O. Sanmartín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Sanmartín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Sanmartín more than expected).

Fields of papers citing papers by O. Sanmartín

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Sanmartín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Sanmartín. The network helps show where O. Sanmartín may publish in the future.

Co-authorship network of co-authors of O. Sanmartín

This figure shows the co-authorship network connecting the top 25 collaborators of O. Sanmartín. A scholar is included among the top collaborators of O. Sanmartín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Sanmartín. O. Sanmartín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Requena, Celia, et al.. (2024). Avelumab en el tratamiento del carcinoma de células de Merkel: experiencia en vida real en un centro monográfico oncológico. Actas Dermo-Sifiliográficas. 116(1). 81–86. 1 indexed citations
2.
Martorell, Antonio, et al.. (2024). Interobserver Variability in the Histopathological Evaluation of Melanoma: Analysis of 60 Cases. Actas Dermo-Sifiliográficas. 116(6). 583–588. 3 indexed citations
3.
Cañueto, Javier, Eva Muñoz‐Couselo, Javier Martín‐Vallejo, et al.. (2024). Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real‐world retrospective study from Spain and systematic review of the published data. Journal of the European Academy of Dermatology and Venereology. 38(8). e666–e670. 1 indexed citations
4.
Requena, Celia, C. Serra‐Guillén, & O. Sanmartín. (2022). Carcinoma basocelular histológicamente agresivo con especial atención a la infiltración galeal del cuero cabelludo. Actas Dermo-Sifiliográficas. 113(6). 575–582. 2 indexed citations
5.
Álvarez, Pablo, Javier Lavernia, C. Serra‐Guillén, et al.. (2022). Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience in a Monographic Oncology Center. Actas Dermo-Sifiliográficas. 113(6). 610–615. 10 indexed citations
6.
Álvarez, Pablo, Javier Lavernia, C. Serra‐Guillén, et al.. (2022). [Artículo traducido] Cemiplimab en el carcinoma de células escamosas cutáneo avanzado: experiencia del mundo real en un centro oncológico monográfico. Actas Dermo-Sifiliográficas. 113(6). T610–T615. 6 indexed citations
7.
Toledo‐Pastrana, Tomás, Celia Requena, A. Diago, et al.. (2021). Localized Injection-site Toxic Erythema of Chemotherapy: An Under-recognized Acquaintance Revisited. Acta Dermato Venereologica. 101(4). adv00429–adv00429. 3 indexed citations
8.
Cañueto, Javier, A. Tejera‐Vaquerizo, Pedro Redondo, et al.. (2020). Revisión de los términos que definen un carcinoma epidermoide cutáneo asociado a mal pronóstico. Actas Dermo-Sifiliográficas. 111(4). 281–290. 8 indexed citations
9.
Requena, Celia, M. Alsina, D. Morgado‐Carrasco, et al.. (2018). Sarcoma de Kaposi y angiosarcoma cutáneo: directrices para el diagnóstico y tratamiento. Actas Dermo-Sifiliográficas. 109(10). 878–887. 18 indexed citations
10.
Serra‐Guillén, C., Eduardo Nagore, B. Llombart, et al.. (2017). Tratamiento con imiquimod al 5% durante 12 días para las queratosis actínicas: estudio de la eficacia y la reacción local. Actas Dermo-Sifiliográficas. 109(3). 248–253. 6 indexed citations
11.
Requena, Celia, B. Llombart, O. Sanmartín, et al.. (2017). Angiosarcoma cutáneo: estudio clínico-patológico de 16 casos. Actas Dermo-Sifiliográficas. 108(5). 457–465. 12 indexed citations
12.
Requena, Celia, V. Través, Eduardo Nagore, et al.. (2014). Dermatomiositis paraneoplásica: estudio de 12 casos. Actas Dermo-Sifiliográficas. 105(7). 675–682. 26 indexed citations
13.
Alfaro‐Rubio, A., Rafael Botella‐Estrada, C. Serra‐Guillén, et al.. (2010). Liquen plano anular y atrófico. Revista Medicina Cutánea Ibero-Latino-Americana. 38(1). 41–44.
14.
Serra‐Guillén, C., Eduardo Nagore, L. Hueso, et al.. (2010). A randomized comparative study of tolerance and satisfaction in the treatment of actinic keratosis of the face and scalp between 5% imiquimod cream and photodynamic therapy with methyl aminolaevulinate. British Journal of Dermatology. 164(2). 429–433. 29 indexed citations
15.
Nagore, Eduardo, B. Llombart, O. Sanmartín, et al.. (2006). Basal cell carcinoma of the nasolabial fold: an apparently ‘benign’ tumour that often needs complex surgery. Journal of the European Academy of Dermatology and Venereology. 20(8). 926–930. 9 indexed citations
16.
Botella‐Estrada, Rafael, Eduardo Nagore, Antonio Cremades, et al.. (2006). Clinical, dermoscopy and histological correlation study of melanotic pigmentations in excision scars of melanocytic tumours. British Journal of Dermatology. 154(3). 478–484. 18 indexed citations
17.
Llombart, B., Carlos Monteagudo, José Antonio López‐Guerrero, et al.. (2005). Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markers. Histopathology. 46(6). 622–634. 157 indexed citations
18.
Sevila, Amparo, Eduardo Nagore, Rafael Botella‐Estrada, et al.. (2004). Videomicroscopy of Venular Malformations (Port‐Wine Stain Type): Prediction of Response to Pulsed Dye Laser. Pediatric Dermatology. 21(5). 589–596. 25 indexed citations
19.
Nagore, Eduardo, Amparo Sevila, O. Sanmartín, et al.. (2003). Excellent response of basal cell carcinomas and pigmentary changes in xeroderma pigmentosum to imiquimod 5% cream. British Journal of Dermatology. 149(4). 858–861. 27 indexed citations
20.
Botella‐Estrada, Rafael, et al.. (1993). Juvenile Xanthogranuloma with Central Nervous System Involvement. Pediatric Dermatology. 10(1). 64–68. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James W. Patterson Breakdown of academic impact, for papers by B. Llombart Breakdown of academic impact, for papers by Wolfgang Weyers Breakdown of academic impact, for papers by H. Adamski Breakdown of academic impact, for papers by Gisela Metzler Breakdown of academic impact, for papers by John S. Metcalf Breakdown of academic impact, for papers by Uma Sundram Breakdown of academic impact, for papers by Stephen N. Snow Breakdown of academic impact, for papers by Jere B. Stern Breakdown of academic impact, for papers by A Margulis
Rankless by CCL
2026